Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PBE vs RYOIX
Shared holdings
20
PBE covered by RYOIX
35.34%
RYOIX covered by PBE
35.34%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 33 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PBE (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 8.92% | |
| ILLUMINA INC | 4.98% | |
| GILEAD SCIENCES INC | 4.91% | |
| AMGEN INC | 4.43% | |
| BIOGEN INC | 4.40% | |
| UNITED THERAPEUTICS CORP DEL | 4.26% | |
| REGENERON PHARMACEUTICALS INC | 4.22% | |
| INCYTE CORP | 4.08% | |
| Invesco Private Government Fund | 3.43% | |
| AMICUS THERAPEUTICS INC | 3.41% | |
| ALNYLAM PHARMACEUTICALS INC | 3.37% | |
| DYNAVAX TECHNOLOGIES CORP | 3.20% | |
| QIAGEN NV ORD SHARES | 2.68% | |
| MANNKIND CORP | 2.66% | |
| IONIS PHARMACEUTICALS INC | 2.49% | |
| ACADIA PHARMACEUTICALS INC | 2.48% | |
| ROYALTY PHARMA-A | 2.48% | |
| CATALYST PHARMACEUTICALS INC | 2.44% | |
| BIOMARIN PHARMACEUTICAL INC | 2.41% | |
| BIO-TECHNE CORP | 2.38% | |
| COLLEGIUM PHARMACEUTICAL INC | 2.38% | |
| EXELIXIS INC | 2.31% | |
| HALOZYME THERAPEUTICS INC | 2.29% | |
| BIOCRYST PHARMACEUTICALS INC | 2.27% | |
| NEUROCRINE BIOSCIENCES INC | 2.27% | |
| PTC THERAPEUTICS INC | 2.23% | |
| PROTAGONIST THERAPEUTICS INC | 2.20% | |
| VERICEL CORP | 2.19% | |
| TG THERAPEUTICS INC | 2.17% | |
| REPLIGEN CORP | 2.11% | |
| MADRIGAL PHARMACEUTICALS INC | 1.97% | |
| VERACYTE INC | 1.93% | |
| Invesco Government & Agency Portfolio, Institutional Class | 0.06% |
RYOIX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| ABBVIE INC | 7.46% | |
| AMGEN INC | 5.28% | |
| GILEAD SCIENCES INC | 5.00% | |
| VERTEX PHARMACEUTICALS INC | 4.04% | |
| REGENERON PHARMACEUTICALS INC | 3.59% | |
| ALNYLAM PHARMACEUTICALS INC | 2.63% | |
| INSMED INC | 2.48% | |
| BEONE MEDICINES LTD ADR | 2.31% | |
| NATERA INC | 2.11% | |
| UNITED THERAPEUTICS CORP DEL | 2.09% | |
| BIOGEN INC | 2.03% | |
| ROYALTY PHARMA PLC | 2.00% | |
| ILLUMINA INC | 1.75% | |
| REVOLUTION MEDICINES INC | 1.71% | |
| MODERNA INC | 1.66% | |
| ASTRAZENECA PLC | 1.62% | |
| ARGENX SE SPONSORED ADR | 1.62% | |
| INCYTE CORP | 1.57% | |
| VIATRIS INC | 1.51% | |
| BRIDGEBIO PHARMA INC | 1.48% | |
| ALKERMES PLC | 1.48% | |
| JAZZ PHARMA PLC | 1.48% | |
| NEUROCRINE BIOSCIENCES INC | 1.43% | |
| GUARDANT HEALTH INC | 1.42% | |
| ROIVANT SCIENCES LTD | 1.41% | |
| IONIS PHARMACEUTICALS INC | 1.40% | |
| EXELIXIS INC | 1.30% | |
| MEDPACE HOLDINGS INC | 1.27% | |
| BIOMARIN PHARMACEUTICAL INC | 1.26% | |
| APELLIS PHARMACEUTICALS INC | 1.24% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.24% | |
| CYTOKINETICS INC | 1.19% | |
| VAXCYTE INC | 1.15% | |
| CRISPR THERAPEUTICS AG | 1.14% | |
| HALOZYME THERAPEUTICS INC | 1.10% | |
| BIONTECH SE ADR | 1.07% | |
| AXSOME THERAPEUTICS INC | 1.03% | |
| Ascendis Pharma A/S | 1.02% | |
| COGENT BIOSCIENCES INC | 1.00% | |
| ARCELLX INC | 1.00% | |
| TG THERAPEUTICS INC | 0.97% | |
| PTC THERAPEUTICS INC | 0.96% | |
| SCHOLAR ROCK HOLDING CORP | 0.95% | |
| MADRIGAL PHARMACEUTICALS INC | 0.91% | |
| MIRUM PHARMACEUTICALS INC | 0.90% | |
| PROTAGONIST THERAPEUTICS INC | 0.88% | |
| AMICUS THERAPEUTICS INC | 0.82% | |
| RHYTHM PHARMACEUTICALS INC | 0.79% | |
| APOGEE THERAPEUTICS INC | 0.76% | |
| KYMERA THERAPEUTICS INC | 0.73% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.